首页> 外文期刊>Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists >Endovascular Exclusion of Thoracic Aortic Aneurysms With the 1- and 2-Component Zenith TX2 TAA Endovascular Grafts: Analysis of 2-Year Data From the TX2 Pivotal Trial.
【24h】

Endovascular Exclusion of Thoracic Aortic Aneurysms With the 1- and 2-Component Zenith TX2 TAA Endovascular Grafts: Analysis of 2-Year Data From the TX2 Pivotal Trial.

机译:带有1和2组分Zenith TX2 TAA血管内移植物的胸主动脉瘤的血管内排除:来自TX2枢纽试验的2年数据分析。

获取原文
获取原文并翻译 | 示例
       

摘要

Abstract Purpose: To compare the midterm results of endovascular treatment of thoracic aortic aneurysms and ulcers in patients who received either a 1-component or 2-component Zenith TX2 stent-graft. Methods: Data were gathered from a prospectively maintained registry for the Zenith TX2 pivotal trial. Among 158 patients who underwent thoracic endovascular aortic repair (TEVAR) between March 2004 and July 2006, 64 received a 1-component stent-graft (group 1) and 94 patients a 2-component device (group 2). Results: In group 2, there were more men (79% vs. 63%; p = 0.03), and the patients had more diagnosed (p<0.01) and previously repaired (p<0.01) abdominal aortic aneurysms. Aneurysms in group 2 were significantly larger in both diameter (63 vs. 56 mm, p<0.01) and length (157 vs. 113 mm, p<0.01). Percent of thoracic aorta covered by the stent-graft was greater in group 2 (80% vs. 50%, p<0.01). Patients in group 2 had a significantly longer operation time (124+/-48 vs. 100+/-39 minutes, p<0.01) and significantly increased estimated blood loss during the procedure (248+/-359 vs. 169+/-139 mL, p = 0.05). Procedural success at 30 days was 95% in group 1 and 85% in group 2 (p = 0.06). Postoperative paraplegia and paraparesis were not observed in group 1, but 9 patients in group 2 (p = 0.01) were affected. Treatment success, endoleak, migration, secondary intervention rate, and all-cause and aneurysm-related mortality were not significantly different between the groups at 30 days, 1 year, and 2 years. Conclusion: TEVAR using 1 or 2 TX2 components has similar results in terms of mortality and midterm treatment success. Patients treated with 2 components showed increased perioperative morbidity, including paraplegia, which may be related to the greater extent of graft coverage required in this patient group, as well as to male gender, previous aortic repair, longer operating time, and increased blood loss.
机译:摘要目的:比较接受1组分或2组分Zenith TX2支架移植物的患者的胸主动脉瘤和溃疡的血管内治疗的中期结果。方法:数据从Zenith TX2关键试验的前瞻性注册表中收集。在2004年3月至2006年7月进行胸腔内血管主动脉修复(TEVAR)的158例患者中,有64例接受了1组件支架植入物(第1组),而94例接受了2组件装置(第2组)。结果:在第2组中,男性较多(79%比63%; p = 0.03),并且患者被诊断(p <0.01)和先前已修复(p <0.01)的腹主动脉瘤较多。第2组的动脉瘤的直径(63 vs. 56 mm,p <0.01)和长度(157 vs. 113 mm,p <0.01)均明显更大。在第二组中,覆膜支架覆盖的胸主动脉百分比更高(80%对50%,p <0.01)。第2组患者的手术时间明显更长(124 +/- 48 vs. 100 +/- 39分钟,p <0.01),并且术中估计失血量明显增加(248 +/- 359 vs. 169 +/-) 139 mL,p = 0.05)。第1组在30天时的手术成功率为95%,第2组为85%(p = 0.06)。第1组未观察到术后截瘫和轻瘫,但第2组中有9例患者受到了影响(p = 0.01)。两组在30天,1年和2年时的治疗成功率,内漏,迁移,二次干预率以及全因和动脉瘤相关的死亡率无显着差异。结论:使用1或2种TX2组分的TEVAR在死亡率和中期治疗成功方面具有相似的结果。用2种成分治疗的患者显示围手术期发病率增加,包括截瘫,这可能与该患者组所需的移植物覆盖范围更大以及男性,先前的主动脉修复,更长的手术时间以及失血量增加有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号